|
Index of reports
> Cases with Febrile Neutropenia (105)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 105 Next >>
Possible Dexamethasone side effects in 59 year old female
Reported by a physician from Japan on 2012-08-18
Patient: 59 year old female
Reactions: Febrile Neutropenia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Dexamethasone
Dosage: 8 mg
Dexamethasone
Dosage: 8 mg
Administration route: Oral
Indication: Supportive Care
Docetaxel
Indication: Breast Cancer
Possible Dexamethasone side effects in 36 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-17
Patient: 36 year old female
Reactions: Febrile Neutropenia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Dexamethasone
Dosage: 8 mg
Dexamethasone
Dosage: 8 mg
Administration route: Oral
Indication: Supportive Care
Docetaxel
Indication: Breast Cancer
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-08-07
Patient: male
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dasatinib
Dosage: one day
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-26
Dexamethasone
Doxorubicin Hydrochloride
Methotrexate
Start date: 2012-05-11
Vincristine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-03
Other drugs received by patient: Ondansetron; Glutamic Acid; Lorazepam; Morphine Sulfate; Bactrim
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in female
Reported by a physician from Belgium on 2012-08-03
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Anaemia, Febrile Neutropenia, Pyrexia, Lung Squamous Cell Carcinoma Stage Unspecified, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Administration route: Oral
Start date: 2011-06-24
End date: 2011-07-20
Dexamethasone
Start date: 2012-07-04
Dexamethasone
Administration route: Oral
Start date: 2012-04-26
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-05-31
Dexamethasone
Start date: 2012-07-02
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
End date: 2012-06-27
Dexamethasone
Start date: 2012-07-03
Revlimid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-04-20
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-04-26
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-24
End date: 2011-12-28
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-05-30
End date: 2012-06-27
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-02-02
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-05-31
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-28
End date: 2011-06-16
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2012-01-05
End date: 2012-01-25
Other drugs received by patient: Aspirin; Cranberry Extract; RED Blood Cells; Paracodeine; Omeprazole; Pantoprazole; Flexium; Meropenem; Symbicort; Flexium; Cetavlex; Polyethylene Glycol; Sodium Chloride; Duovent; Aspirin; Bisoprolol Fumarate; R Calm Creme; RED Blood Cells; Platelets; Platelets; Whole Blood; Paracodeine
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-02
Patient:
Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Atrial Fibrillation, Febrile Neutropenia, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Lenalidomide
Dosage: 5 or 10mg (daily,days 1-21 of ea cycle)
Administration route: Oral
Indication: Multiple Myeloma
Treanda
Dosage: 75 or 100mg/m2 (day 1 and 2 of ea cycle)
Indication: Multiple Myeloma
Other drugs received by patient: Gastroprotectant; Acetylsalicylic Acid SRT
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-31
Patient:
Reactions: Mantle Cell Lymphoma Refractory, Skin Toxicity, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Cardiotoxicity, Thrombocytopenia, Renal Disorder, Drug Effect Decreased, Gastrointestinal Toxicity, Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Mantle Cell Lymphoma, Lung Disorder, Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Chlorambucil
Dosage: from day 20 to 29.
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: day 1 to 4
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: on day 1 (and day 8 of cycle 1)
Indication: Mantle Cell Lymphoma
Velcade
Dosage: on days 1, 4, 8 and 11
Indication: Mantle Cell Lymphoma
Possible Dexamethasone side effects in female
Reported by a physician from Belgium on 2012-07-30
Patient: female, weighing 62.6 kg (137.7 pounds)
Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased, Pyrexia, Lung Squamous Cell Carcinoma Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Start date: 2012-07-02
Dexamethasone
Start date: 2012-07-03
Dexamethasone
Administration route: Oral
Start date: 2011-06-24
End date: 2011-07-20
Dexamethasone
Administration route: Oral
Start date: 2012-04-26
Dexamethasone
Start date: 2012-07-04
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-05-31
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
End date: 2012-06-27
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-28
End date: 2011-06-16
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2012-01-05
End date: 2012-01-25
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-02-02
Revlimid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-04-20
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-06-24
End date: 2011-12-28
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-04-26
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-05-31
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-05-30
End date: 2012-06-27
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-05
Other drugs received by patient: R Calm Creme; RED Blood Cells; Cetavlex; Flexium; Platelets; Polyethylene Glycol; Aspirin; Meropenem; Bisoprolol Fumarate; Flexium; Sodium Chloride; Symbicort; Cranberry Extract; Pantoprazole
Possible Dexamethasone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Velcade
End date: 2012-04-10
Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-30
Patient: male
Reactions: Staphylococcal Infection, Atrial Flutter, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Bortezomib
Indication: Multiple Myeloma
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Romidepsin
Indication: Multiple Myeloma
Other drugs received by patient: Bisphosphonates; Sulfamethoxazole and Trimethoprim; Valaciclovir
Possible Dexamethasone side effects in
Reported by a physician from Israel on 2012-07-28
Patient:
Reactions: Febrile Neutropenia, Hyponatraemia, Pyrexia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Cisplatin
Dosage: 46.2 mg/kg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Cytoxan
Dosage: 172 mg, qd
Indication: Chemotherapy
Start date: 2012-06-19
End date: 2012-06-20
Dexamethasone
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Dexamethasone
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Etoposide
Dosage: 33 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-20
Ondansetron
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-06-18
End date: 2012-06-22
Placebo
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Placebo
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Vincristine Sulfate
Dosage: 0.6 mg, qd
Start date: 2012-06-24
End date: 2012-06-24
Vincristine Sulfate
Dosage: 0.66 mg, qd
Start date: 2012-07-01
End date: 2012-07-01
Vincristine Sulfate
Dosage: 0.66 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Other drugs received by patient: Dexacort (Dexamethasone Sodium Phosphate); Mesna; Resprim; Diamox
Possible Dexamethasone side effects in female
Reported by a physician from Sweden on 2012-07-26
Patient: female, weighing 68.5 kg (150.7 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-05-19
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-05-20
Dexamethasone
Dosage: 40mg every 3 weeks
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-05-19
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-05-19
Possible Dexamethasone side effects in 1 year old male
Reported by a physician from United States on 2012-07-25
Patient: 1 year old male
Reactions: Adenovirus Infection, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Start date: 2011-05-27
Lestaurtinib
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-05-27
Mercaptopurine
Start date: 2011-05-27
Methotrexate
Start date: 2011-05-27
Vincristine
Start date: 2011-05-27
Possible Dexamethasone side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-23
Patient: male, weighing 54.0 kg (118.8 pounds)
Reactions: White Blood Cell Count Decreased, Pneumonia, Chills, Anaemia, Febrile Neutropenia, Pyrexia, Oropharyngeal Pain, Fatigue, Respiratory Failure, Tachypnoea, Cough, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 135 mg
Mercaptopurine
Dosage: 8000 mg
Methotrexate
Dosage: 270 mg
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23
Patient:
Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Febrile Neutropenia, Atrial Fibrillation, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 75 or 100mg/m2
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Revlimid
Dosage: 5 or 10mg
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Gastroprotectant; Aspirin
Possible Dexamethasone side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20
Patient: 42 year old female
Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Dexamethasone
Dosage: 12mg
Indication: Premedication
Dithiaden
Dosage: 2mg
Indication: Premedication
Docetaxel
Dosage: for 4 cycles
Indication: Breast Cancer
Doxorubicin HCL
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Ondansetron
Dosage: 8mg
Indication: Antiemetic Supportive Care
Paclitaxel
Dosage: over 1h on d1; part of act protocol; scheduled for 12w
Indication: Breast Cancer
Ranitidine
Dosage: 150mg
Indication: Premedication
Possible Dexamethasone side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20
Patient: 42 year old female
Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Dexamethasone
Dosage: 12mg
Indication: Premedication
Dithiaden
Dosage: 2mg
Indication: Premedication
Docetaxel
Dosage: for 4 cycles
Indication: Breast Cancer
Doxorubicin HCL
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Ondansetron
Dosage: 8mg
Indication: Antiemetic Supportive Care
Paclitaxel
Dosage: over 1h on d1; part of act protocol; scheduled for 12w
Indication: Breast Cancer
Ranitidine
Dosage: 150mg
Indication: Premedication
Possible Dexamethasone side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20
Patient: 42 year old female
Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Dexamethasone
Dosage: 12mg
Indication: Premedication
Dithiaden
Dosage: 2mg
Indication: Premedication
Docetaxel
Dosage: for 4 cycles
Indication: Breast Cancer
Doxorubicin HCL
Dosage: on d1; part of act protocol; for 4 cycles
Indication: Breast Cancer
Ondansetron
Dosage: 8mg
Indication: Antiemetic Supportive Care
Paclitaxel
Dosage: over 1h on d1; part of act protocol; scheduled for 12w
Indication: Breast Cancer
Ranitidine
Dosage: 150mg
Indication: Premedication
Possible Dexamethasone side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-19
Patient: 42 year old female
Reactions: Febrile Neutropenia, Suicidal Ideation, Dysphemia, Anxiety, Hallucinations, Mixed, Transient Psychosis, Disturbance in Attention, Somatoform Disorder, Hallucination
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bisulepin
Dosage: 2 mg
Indication: Premedication
Dexamethasone
Dosage: 12 mg
Indication: Premedication
Ondansetron
Dosage: 8 mg
Indication: Premedication
Paclitaxel
Dosage: 80 mg/m2, per week
Indication: Breast Cancer
Ranitidine
Dosage: 150 mg
Indication: Premedication
Other drugs received by patient: Cyclophosphamide; Doxorubicin HCL
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-19
Patient:
Reactions: Mantle Cell Lymphoma Refractory, Skin Toxicity, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Cardiotoxicity, Thrombocytopenia, Drug Effect Decreased, Renal Disorder, Gastrointestinal Toxicity, Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Mantle Cell Lymphoma, Lung Disorder, Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Chlorambucil
Dosage: from day 20 to 29.
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: day 1 to 4
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: on day 1 (and day 8 of cycle 1)
Indication: Mantle Cell Lymphoma
Velcade
Dosage: on days 1, 4, 8 and 11
Indication: Mantle Cell Lymphoma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient:
Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Revlimid
Dosage: 15 milligram
Administration route: Oral
Velcade
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 milligram/sq. meter
Possible Dexamethasone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore
Possible Dexamethasone side effects in
Reported by a physician from Israel on 2012-07-17
Patient:
Reactions: Febrile Neutropenia, Hyponatraemia, Pyrexia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Cisplatin
Dosage: 46.2 mg/kg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Cytoxan
Dosage: 172 mg, qd
Indication: Chemotherapy
Start date: 2012-06-19
End date: 2012-06-20
Dexamethasone
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Dexamethasone
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Etoposide
Dosage: 33 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-20
Ondansetron
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-06-18
End date: 2012-06-22
Placebo
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Placebo
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Vincristine Sulfate
Dosage: 0.66 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Vincristine Sulfate
Dosage: 0.6 mg, qd
Start date: 2012-06-24
End date: 2012-06-24
Vincristine Sulfate
Dosage: 0.66 mg, qd
Start date: 2012-07-01
End date: 2012-07-01
Other drugs received by patient: Dexacort (Dexamethasone Sodium Phosphate); Resprim; Diamox; Mesna
Possible Dexamethasone side effects in female
Reported by a individual with unspecified qualification from Netherlands on 2012-07-13
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Febrile Neutropenia, Pyrexia, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: last dose prior to sae 05/jun/2012
Start date: 2012-06-05
Cisplatin
Dosage: last dose prior to sae 05/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-04
Cytarabine
Dosage: last dose prior to sae 06/jun/2012
Start date: 2012-06-06
Cytarabine
Dosage: last dose prior to sae 05/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-05
Dexamethasone
Dosage: last dose prior to sae 07/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-04
Dexamethasone
Dosage: last dose prior to sae 08/jun/2012
Start date: 2012-06-05
Mabthera
Dosage: last dose prior to sae 08/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-08
Mabthera
Dosage: last dose prior to sae 09/jun/2012
Start date: 2012-06-09
Other drugs received by patient: Augmentin '125'; Ciprofloxacin HCL; Nexium; Fungizone; Keppra; Keppra; Valganciclovir; Allopurinol
Possible Dexamethasone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride
Possible Dexamethasone side effects in 61 year old female
Reported by a physician from United States on 2012-07-13
Patient: 61 year old female, weighing 62.1 kg (136.7 pounds)
Reactions: Chills, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20mg, day of+aft velcade
Indication: Multiple Myeloma
Start date: 2012-07-02
End date: 2012-07-10
Velcade
Dosage: 1.3mg, d 1,4,8,11
Indication: Multiple Myeloma
Start date: 2012-07-02
End date: 2012-07-09
Other drugs received by patient: Acyclovir; Lovenox; Prilosec; Compazine; Oxycodone HCL; Ativan; Ondansetron Hydrochloride
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient:
Reactions: Bacteraemia, Febrile Neutropenia, Haematotoxicity
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Cytarabine
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Dexamethasone
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Mabthera
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Methotrexate
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Vincristine
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Possible Dexamethasone side effects in
Reported by a individual with unspecified qualification from Croatia (Local Name: Hrvatska) on 2012-07-13
Patient:
Reactions: Mucosal Inflammation, Multi-Organ Failure, Tumour Lysis Syndrome, Febrile Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Dexamethasone
Indication: Burkitt's Lymphoma
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Ifosfamide
Indication: Burkitt's Lymphoma
Mabthera
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Prophylaxis
Prednisone
Indication: Burkitt's Lymphoma
Vincristine
Indication: Burkitt's Lymphoma
Possible Dexamethasone side effects in 46 year old male
Reported by a physician from United States on 2012-07-12
Patient: 46 year old male
Reactions: Febrile Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 446 mg, unk
Cyclophosphamide
Dosage: 630 mg, q12h
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Doxorubicin HCL
Dosage: 56.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Doxorubicin HCL
Dosage: 37 mg, unk
Mesna
Dosage: 1116 mg, unk
Indication: non-Hodgkin's Lymphoma
Pegfilgrastim
Dosage: 6 mg, unk
Indication: non-Hodgkin's Lymphoma
Rituxan
Dosage: 698 mg, unk
Start date: 2012-05-02
Rituxan
Dosage: 787.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Other drugs received by patient: MS Contin; Valtrex; Omeprazole; Ciprofloxacin; Morphine Sulfate; Enoxaparin / 01708202 /; Compazine; Fluconazole; Metoprolol Tartrate
Possible Dexamethasone side effects in 61 year old female
Reported by a physician from United States on 2012-07-11
Patient: 61 year old female, weighing 61.4 kg (135.1 pounds)
Reactions: Anaemia, Chills, Febrile Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: day of and after velcade
Indication: Multiple Myeloma
Start date: 2012-07-02
End date: 2012-07-03
Revlimid
Dosage: days 1-14
Indication: Multiple Myeloma
Start date: 2012-07-02
End date: 2012-07-03
Velcade
Dosage: days 1, 4, 8, 11
Indication: Multiple Myeloma
Start date: 2012-07-02
End date: 2012-07-02
Other drugs received by patient: Prilosec; Lovenox; Acyclovir
Page 1 Next >>
|
